Skip to main content
. 2019 May 9;36(Suppl 1):25–44. doi: 10.1007/s40266-019-00664-x

Fig. 6.

Fig. 6

Relative risk of hypertension adverse events for COX-2 inhibitors versus placebo. CI confidence interval, COX-2 cyclooxygenase-2, RR relative risk